UPDATE: CABRINI’S COVID-19 RESPONSE
We currently have precautionary measures in place to protect our patients, staff and residents. Read more

The Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology

About the musculoskeletal health and clinical epidemiology research department

The Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology performs high-quality clinical research to answer clinically important questions, and to promote the translation of clinical evidence into practice and policy change. Our current program of work concerns identifying and reducing low-value health care arising from over-diagnosis and over-treatment, and identifying ways to improve the sustainability of the health care system.

In 2018, we launched the NHMRC Centre of Research Excellence for the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network. We continue to manage the Australian Rheumatology Association Database and are an editorial base for Cochrane Musculoskeletal and Australasian Satellite of Cochrane Effective Practice and Organisation of Care (EPOC).

Team members

  • NSW Agency for Clinical Innovation (ACI) Unwarranted Clinical Variation Grant. ‘A structured implementation approach to reduce unwarranted clinical variations’. (2022 –2023), $100,000 Glasziou P, Thomas R, Moynihan R, O’Connor D, Albarqouni L.
  • NHMRC Centres of Research Excellence (CRE). Wiser healthcare: Better value care for all Australians. (ID2006545) (2022 – 2026), $2,500,000 McCaffery KJ, Carter SM, Barratt AL, Bell CJL, Moynihan RN, O’Connor DA, Maher CG, Buchbinder R, Houssami N, Glasziou PP.
  • NHMRC-NIHR Collaborative Research Grant Round 2. Reverse or anatomical (replacement) for painful shoulder osteoarthritis: Differences between interventions –
    Australia. (ID2008140) (2022 – 2026), $1,540,874 Page R, Foster N, Harris I, Buchbinder R, Gill S, Graves S, Ackerman I, O’Connor DA, Comans T, Billot L.
  • NHMRC Clinical Trials and Cohort Studies Grant. A scalable insomnia program during the Pregnancy and postpartum periods: An effectiveness-implementation hybrid
    Trial (ID2001834). (2022 – 2025), $877,335 Bei B, Manber R, Drummond S, Wiley J, Mortimer D, O’Connor DA, Mol B, Rolnik D, Davey M.
  • NHMRC Centre for Research Excellence. ‘Better outcomes in inflammatory arthritis’(APP2006579). (2022 – 2026) $2,500,00.March L, Thomas R, Lassere M, Buchbinder R, Hill C, Keen H, Wechalekar M, Munro J, Figtree G, Schofield D.
  • NHMRC Investigator Grant: Leadership 3. ‘Better evidence more rapidly implemented to optimise health for people with musculoskeletal conditions’. APP1194483. (2022-2025), $2,914,215 Buchbinder R.
  • MRFF-PPHR Initiative. ‘Efficient use of existing medicines: Cost-utility comparison of down-titration strategies for safer and more efficient use of biologics in adults with rheumatoid arthritis and psoriatic arthritis’. (2021 – 2025), $2,720,943 March L, Buchbinder R, Lassere M, Proudman S, Thomas R, Schofield D, Xue M, Wechalekar M, Whittle S.
  • NHMRC Ideas Grant. ‘Enabling evidence-informed policy to address Australia’s opioid crisis’. APP2002193. (2021-2024), $607,538 Nielsen S, Bell S, Lalic, Russel G, AI: Buchbinder R.
  • MRFF-PPHR Initiative. Efficient use of existing medicines. ‘Cost-utility comparison of down-titration strategies for safer and more efficient use of biologics in adults with rheumatoid arthritis and psoriatic arthritis’. (2021-2025), $2,720,943 March L, Buchbinder R, Lassere M, Proudman S, Thomas R, Schofield D, Xue M, Wechalekar M, Whittle S.
  • Victorian Department of Health and Human Services (DHHS) Victorian Healthcare Recovery Initiative Grant. ‘Measuring, providing regular feedback and co-designing quality improvement strategies to reduce low-value colonoscopy’. (2021-2022), $325,000 O’Connor DA, Hiscock H, Audehm R, Hensher M, Hutchinson A, Liew D, O’Loughlin A, Thursky K.
  • Swedish Research Council – Joint Programming Initiative on Antimicrobial Resistance Fund. ‘The Joint Programming Initiative on Antimicrobial Resistance Network Plus (JPIAMR) audit and feedback international collaboration: Best practices for the delivery of antibiotic prescribing feedback to community clinicians using behavioural science’. (2021-2022), €200,000 (AU$325,000) Schwartz K, Lindbaek M, Ivers N on behalf of JPIAMR International Network; O’Connor DA (Australian CI).
  • Monash Partners Advanced Health Research Translation Centre MRFF 2020. ‘Development of an embedded, sustainable platform to identify low-value care across Monash Partners healthcare services’. (2021-2022), $80,000 O’Connor DA.
  • NHMRC Clinical Trials and Cohort Studies Grant. (ID2001834): ‘A scalable insomnia program during the pregnancy and postpartum periods: An effectiveness-implementation hybrid trial’. (2021-2025), $877,335 Bei B, Manber R, Drummond S, Wiley J, Mortimer D, O’Connor D, Mol B, Rolnik D, Davey M.
  • Cabrini Foundation Research Grant. Psychocultural and practical factors related to Australian adults’ comprehension and utilisation of overtesting and overdiagnosis information: a mixed-methods study. (2021-2022), $29,739.70 Rozbroj T, Wallis J, Haas R, O’Connor D, Buchbinder R.
  • ‘NHMRC Low Back Pain Centre for Research Excellence (CRE)’. APP1171459. (2020-2024), $2,499,189 Maher C, Buchbinder R, Hancock M, O’Sullivan P, McAuley J, Blyth F, Jorm L, Collie A, McCaffery K, Hayes A (AI O’Connor D).
  • NHMRC. The Cochrane Collaboration Round 8 Funding Program. ‘Cochrane Musculoskeletal Review Group, Australian Editorial base’. (2020-2023), $384,204 Buchbinder R, Johnston R, O’Connor D, Winzenberg T, Maher C, Whittle S.
  • Australian Government Department of Health. ‘Public Health and Chronic Disease Program Arthritis – Health Professional Education and Training’. (2020-2023), $2,018,464 Partnership between: Arthritis Australia, University of Sydney, University of Melbourne, Arthritis and Osteoporosis Australia in partnership with Curtin University, Monash University on behalf of ANZMUSC and Cochrane Musculoskeletal, Australian Rheumatology Association.
  • National COVID-19 Clinical Evidence Taskforce. (2020-2025), Equity Trustees – Walter Cottman Endowment Fund: $100,000 (25/3/20 to 31/12/20); Ian Potter Foundation: $2,500,000 (1/4/2020 to 31/12/2025); MRFF: $1,500,000 (1/4/2020 to 31/3/2022) Elliott J, Green S, Zoungas S, Buchbinder R, Craig J, McGowan S, Tendal B, Tate R, Turner T, McDonald S, Murano M.
  • NHMRC Ideas Project. ‘TOPCHILD: Transforming Obesity Prevention for CHILDren – Looking into the black box of interventions’. (2020-2023), $411,926 CIA Seidler L; O’Connor D (AI).
  • NHMRC Project Grant. ‘Trial of glucocorticoids in acute sciatica’. APP1157835. (2019-2022), $1,142,038 Lin CWC, McLachlan A, Latimer J, Abdel Shaheed C, Li Q. Buchbinder R (AI) [formerly CI but changed to AI in view of successful Program Grant].
  • Australian Government Department of Health. ‘Value in Prescribing Program: Biological disease modifying anti-rheumatic drugs (bDMARDs): Value-based prescribing of bDMARDs: a coordinated national program’. (2019-2022), $8,411,403 Partnership between: NPS MedicineWise (Dartnell J, London J, Heaney A, Hosking K, Yoo J, Elliott J, Granger R, Blogg S, Antonio G), ARA (Hill C, Barrett C, Morabani M, Kubler P, Day R, Clancy M, Buchbinder R [also representing ANZMUSC and Cochrane Musculoskeletal]), ANZMUSC (Whittle S, O’Connor D), Cochrane Musculoskeletal (Johnston R), Arthritis Australia (Mills A, Marine F), Quality Use of Medicines and Pharmacy Research Centre (Rowett D, Roughead L, Ward M, Wiese M), Pharmaceutical Society of Australia (Jackson S, Freeman C, McMaugh J, Ridd J), Society of Hospital Pharmacists of Australia (Michaels K, Jerry Yik J, Hayward K), Council of Australian Therapeutic Advisory Groups (Etherton-Beer C, Donnelly J, Bennett S).
  • NHMRC Centre of Research Excellence. ‘ANZMUSC – Australia and New Zealand Musculoskeletal Clinical Trials Network’. APP1134856. (2018-2022), $2,497,653 Buchbinder R, Maher C, March L, Day R, Hinman R, Harris I, Ferreira M, Glasziou P, Green S, Billot L.
  • NHMRC Medical Research Future Fund (MRFF) Research Grant. ‘CRISTAL: Cluster randomised trial of aspirin versus Low molecular weight heparin for venous thromboembolism prophylaxis in joint replacement surgery, a registry-nested study’. APP1152285. (2018-2022), $910,700 Harris I, Graves S, Buchbinder R, Naylor J, Pratt N, de Steiger R, Chong B, Ackerman I, Harris A.
  • ‘NHMRC Partnership Centre in Health System Sustainability’. (2017-2022), $10,700,000 (NHMRC $5,250,000; Partners: Bupa Health Foundation, NSW Health, Telstra and the University of Notre Dame Australia) Braithwaite J, Ward RL, Anderson T, Teede H, Wells L, Gray LC, Yeend T, Coiera E, Westbrook J, Glasziou P, Scott A, Karnon JD, Buchbinder R.
  • Academy of Finland. ‘Finnish Imaging of Degenerative Shoulder Study (FIMAGE): A study on the prevalence of degenerative imaging changes of the shoulder and their relevance to clinical symptoms in the general population’. (2018-2022), $450,000 Taimela S, et al.
  • Ackerman IN, Ayton D. (2021) Orthopaedic surgeons’ perceptions of the changing burden of revision joint replacement surgery in Australia: A qualitative study. Musculoskeletal Care. (Epub ahead of print) doi: 10.1002/msc.1582.
  • Anderson DB, Beard DJ, Sabet T, Eyles JP, Harris IA, Adie S, Buchbinder R, Maher CG, Ferreira ML. (2021) Evaluation of placebo fidelity and trial design methodology in placebo controlled surgical trials of musculoskeletal conditions: a systematic review. Pain (Epub ahead of print) doi: 10.1097/j.pain.0000000000002432
  • Andrés M, Sivera F, Buchbinder R, Pardo JP, Carmona L. (2021) Dietary supplements for chronic gout (Update). Cochrane Database Syst Rev 10:CD010156. doi: 10.1002/14651858.CD010156.pub2.
  • Beard DJ, Campbell MK, Blazeby JM, Carr AJ, Weijer C, Cuthbertson BH, Buchbinder R, Pinkney T, Bishop FL, Puch J, Cousins S, Harris I, Lohmander LS, Blencowe N, Gillies K, Probst P, Brennan C, Cook A, Farrar-Hockley D, Savulescu J, Huxtable R, Rangan A, Tracey I, Brocklehurst P, Ferreira ML, Nicholl J, Reeves BC, Hamdy F, Rowley SCs, Lee N, Cook JA. (2021) Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop. Health Technol Assess 25(53):1 – 52.
  • Bennell KL, Bayram C, Harrison C, Brand C, Buchbinder R, Haas R, Hinman RS. (2021) Trends in management of hip and knee osteoarthritis in general practice in Australia over an 11-year window: a nationwide cross-sectional survey. The Lancet Regional Health – Western Pacific. 12:100187 doi:10.1016/j.lanwpc.2021.100187.
  • Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kazsa J, Wang Y, Cicuttini F, Buchbinder R, Forbes A, Harris A, Yu SP, Connell D, Linklater J, Want BH, Hunter DJ. (2021) Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA 326(20):2021-30.
  • Bloom A, Mudiyansalage VW, Rhodes A, Hogg M, Jayasekera C, Gorelik A, Sood S, Nicoll A. (2021) Can adequate analgesia be achieved in patients with cirrhosis without precipitating hepatic encephalopathy? A prospective study. Clin Exp Hepatol. 6(3):243-252. doi:10.5114/ceh.2020.99521.
  • Bråten LC, Johnston RV, Järvinen T, Suter C, Saku S, Buchbinder R. (2021) Pharmacological treatment for prevention of fractures in men. (Protocol) Cochrane Database Syst Rev 8:CD014707. doi: 10.1002/14651858.CD014707
  • Buchbinder R, Haas R. (2021) Optimising treatment for patients with rotator cuff disorders. [Invited Commentary] The Lancet 398(10298):369-70.
  • Buchbinder R, Bourne A, Staples M, Gorelik A, Lui C, Walker K, Ben-Meir M, Blecher G. (2021) Management of patients presenting with low back pain to a private hospital emergency department in Melbourne, Australia. Emerg Med Australas. doi.org/10.1111/1742-6723.13814
  • Busse JW, Vankrunkelsven P, Zeng L, Heen AF, Merglen A, Campbell F, Petter L, Aertgeerts B, Buchbinder R, Coen M, Juurlink D, Samer C, Siemieniuk RAC, Kumar N, Cooper L, Brown J Lytvyn L, Zeraatkar D, Wang Li, Guyatt GH, Vandvik PO, Agoritsas T. (2021) Medical cannabis for chronic pain: a clinical practice guideline. BMJ 374:n2040. doi: 10.1136/bmj.n2040.
  • Cahill LS, Carey LM, Mak-Yuen Y, McCluskey A, Neilson C, O’Connor DA, Lannin NA. (2021) Factors influencing allied health professionals’ implementation of upper limb sensory rehabilitation for stroke survivors: a qualitative study to inform knowledge translation. BMJ Open. 11:e042879. doi:10.1136/bmjopen-2020-042879.
  • Cherry TJ, Gorelik A, Miller JA. (2021) Evolution of surgical management for phaeochromocytoma over a 17-year period: an Australian perspective. ANZ J Surg. doi:10.1111/ans.16847.
  • Coombs D, Machado GC, Richards B, Needs C, Buchbinder R, Harris IA, Howard K, McCaffery K, Billot L, Edwards J, Rogan E, Facer R, Greenberg R, Maher CG, for the SHaPED Investigators. (2021) An implementation trial of emergency care for low back pain. BMJ Qual Safety. doi:10.1136/bmjqs-2020-012337.
  • Di Donato MF, Xia T, Iles R, Buchbinder R, Collie A. (2021) Patterns of opioid dispensing and associated wage replacement duration in workers with accepted claims for low back pain: a retrospective cohort study. Pain. (Epub ahead of print) doi: 10.1097/j.pain.0000000000002539. Online ahead of print.
  • Di Donato MF, Iles R, Buchbinder R, Xia T, Collie A. (2021) Prevalence, predictors and wage replacement duration associated with diagnostic imaging in Australian workers with accepted claims for low back pain: a retrospective cohort study. J Occup Rehab. doi:10.1007/s10926-021-09981-8.
  • Docking SI, Hart HF, Rio E, Hannington MC, Cook JL, Culvenor AG. (2021) Explaining variability in the prevalence of Achilles tendon abnormalities: A systematic review with meta-analysis of imaging studies in asymptomatic individuals. J Orthop Sports Phys Ther. 51(5):232-52. doi:10.2519/jospt.2021.9970.
  • Docking SI, Rio E, Girdwood MA, Hannington MC, Cook JL, Culvenor AG. (2021) Resonance imaging partly explain variability in the prevalence of patellar tendon abnormalities: A systematic review with meta-analysis of imaging studies in asymptomatic individuals. J Orthop Sports Phys Ther. 51(5):216-231. doi:10.2519/jospt.2021.10054.
  • Docking S. (2021) Reducing diagnostic errors related to medical imaging. The Health Advocate. 63:60-3.
  • Farmer C, O’Connor D, Lee H, McCaffrey K, Maher C, Newell D, Cashin A, Byfield D, Jarvik J, Buchbinder R. (2021) Consumer understanding of terms used in imaging reports requested for low back pain. BMJ Open 11:e049938. doi:10.1136/bmjopen-2021-04993.
  • Ferreira GE, Buchbinder R, Zadro JR, O’Keeffe M, Kharel P, Carballo-Costa L, Oliveira J, Maher CG. (2021) Are musculoskeletal conditions neglected in national health surveys? Rheumatol. doi:10.1093/rheumatology/keab025.
  • Ferreira GE, Zadro JR, O’Keeffe M, Buchbinder R, Maher CM, Latimer J, on behalf of the ANZMUSC Clinical Trial Network. (2021) Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Intern Med J. 51(4):622. doi:10.1111/imj.15254.
  • Gearon E, Wallis J, Han JX, O’Connor D, Shepperd S, Mäkelä P, Buchbinder R. (2021) Factors influencing the implementation of early discharge hospital at home and admission avoidance hospital at home: a qualitative evidence synthesis (Protocol). Cochrane Database Sys Rev. 3:CD014765. doi:10.1002/14651858.CD014765.
  • Gilbert S, Buchbinder R, Harris IA, Maher CG. (2021) A comparison of the distribution of Medical Research Future Fund grants with disease burden in Australia. Med J Aust. 214(3):111-113.e1. doi:10.5694/mja2.50916.
  • Farmer C, O’Connor D, Lee H, McCaffrey K, Maher C, Newell D, Cashin A, Byfield D, Jarvik J, Buchbinder R. (2021) Consumer understanding of terms used in imaging reports requested for low back pain. BMJ Open 11:e049938. doi:10.1136/bmjopen-2021-04993.
  • Ferreira GE, Buchbinder R, Zadro JR, O’Keeffe M, Kharel P, Carballo-Costa L, Oliveira J, Maher CG. (2021) Are musculoskeletal conditions neglected in national health surveys? Rheumatol. doi:10.1093/rheumatology/keab025.
  • Ferreira GE, Zadro JR, O’Keeffe M, Buchbinder R, Maher CM, Latimer J, on behalf of the ANZMUSC Clinical Trial Network. (2021) Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Intern Med J. 51(4):622. doi:10.1111/imj.15254.
  • Gearon E, Wallis J, Han JX, O’Connor D, Shepperd S, Mäkelä P, Buchbinder R. (2021) Factors influencing the implementation of early discharge hospital at home and admission avoidance hospital at home: a qualitative evidence synthesis (Protocol). Cochrane Database Sys Rev. 3:CD014765. doi:10.1002/14651858.CD014765.
  • Gilbert S, Buchbinder R, Harris IA, Maher CG. (2021) A comparison of the distribution of Medical Research Future Fund grants with disease burden in Australia. Med J Aust. 214(3):111-113.e1. doi:10.5694/mja2.50916.
  • Glennon V, Whittle SL, Hill CL, Johnston RV, Avery JC, Grobler L, McKenzie BJ, Cyril S, Pardo Pardo J, Buchbinder R. (2021) Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs) (Protocol). Cochrane Database Syst Rev 11:CD014898. doi: 10.1002/14651858.CD014898.
  • Haas R, Busija L, Gorelik A, O’Connor DA, Pearce C, Mazza D, Buchbinder R. (2021) Patterns of care for people presenting to Australian general practice with musculoskeletal complaints based on routinely collected data: protocol for an observational cohort study using the Population Level Analysis and Reporting (POLAR) database. BMJ Open 11(9):e055528.
  • Harris I, Buchbinder R. (2021) How doctors are betraying the Hippocratic Oath. [Invited Opinion Piece] BMJ 375:n2808.
  • Harris IA, Cashman K, Lorimer M, Peng Y, Ackerman I, Heath E, Graves SE. (2021) Are responders to patient health surveys representative of those invited to participate? An analysis of the Patient- Reported Outcome Measures Pilot from the Australian Orthopaedic Association National Joint Replacement Registry. PLoS One 16(7):e0254196.
  • Karjalainen TV, Silagy M, O’Bryan E, Johnston RV, Cyril S, Buchbinder R. Autologous blood and platelet rich plasma injection therapy for lateral elbow pain (Review). Cochrane Database Syst Rev 9:CD010951. doi: 10.1002/14651858.CD010951.pub2.
  • Kerr MM, Graves SE, Duszynski KM, Inacio MC, de Steiger RN, Harris IA, Ackerman IN, Jorm LR, Lorimer MF, Gulyani A, Pratt NL. Does a Prescription-based Comorbidity Index Correlate with the American Society of Anesthesiologists Physical Status Score and Mortality After Joint Arthroplasty? A Registry Study. Clin Orthop Relat Res 479(10):2181-90.
  • Kyi M, Gorelik A, Reid J, Rowan LM, Wraight PR, Colman PG, Fourlanos S. (2021) Clinical prediction tool to identify adults with Type 2 Diabetes at risk for persistent adverse glycemia in hospital. 45(2):114-21.e3. doi:10.1016/j.jcjd.2020.06.006.
  • Lawson A, Naylor J, Buchbinder R, Ivers R, Balogh Z, Smith P, Mittal R, Xuan W, Howard K, Vafa A, Yates P, Rieger B, Smith G, Elkinson I, Kim W, Sungaran J, Latendresse K, Wong J, Viswanathan S, Landale K, Drobetz H, Tran P, Page R, Hau R, Mulford J, Incoll I, Kale M, Schick B, Higgs A, Oppy A, Perriman D, Harris I. (2021) Surgical plating vs closed reduction for fractures in the distal radius in older patients: A randomised clinical trial. JAMA Surg. e205672. doi:10.1001/jamasurg.2020.5672.
  • Lee DYL, Haas R, Wallis J, O’Connor DA, Buchbinder R. (2021) Clinical practice guidelines for the management of atraumatic shoulder conditions: protocol for a systematic review. BMJ Open. 11(4):e048297. doi:10.1136/bmjopen-2020-048297.
  • Liu C, Abdel Shaheed C, Bråten LC, Hancock MJ, Underwood M, Elliott J, Jarvik JG, Maher CG, Buchbinder R, Lin C-WC. Antibiotic treatment for low back pain or radicular pain, or both (Protocol). Cochrane Database Syst Rev 2021, Issue 9. Art. No.: CD014221.
  • McKenzie BJ, Wechalekar MD, Johnston RV, Schlesinger N, Buchbinder R. (2021) Colchicine for acute gout. Cochrane Database Syst Rev 8:CD006190. doi: 10.1002/14651858.CD006190.pub3.
  • Merner B, Lowe D, Schonfeld L, Walsh L, Stratil J, Lewin S, Ryan R, Synnot A, von Philipsborn P, O’Connor D, Glenton C, Hoving J, Hill S. (2021) Stakeholder involvement in systematic reviews: lessons from Cochrane’s Public Health and Health Systems Network. Am J Public Health. 111(7):1210-1215. doi:10.2105/AJPH.2021.306252.
  • Oliveira C, Hamilton M, Traeger A, Buchbinder R, Richards B, Rogan E, Maher CG, Machado GC. (2021) Do patients with acute low back pain in emergency departments have more severe symptoms than those in general practice? A systematic review with meta-regression. Pain Med pnab260. (Epub ahead of print) doi: 10.1093/pm/pnab260.
  • Putrik P, Grobler L, Lalor A, Karnon J, Parker D, Morgan M, Buchbinder R, O’Connor D. (2021) Models for delivery and coordination of primary and/or specialist healthcare to older adults living in aged care facilities (Protocol). Cochrane Database of Systematic Reviews. 3:CD013880.
  • Putrik P, Jessup R, Buchbinder R, Glasziou P, Karnon J, O’Connor DA. (2021) Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders. Aust Health Rev. 45(4):425-432. doi:10.1071/AH20160.
  • Rischin A, Liew D, Black R, Fletcher A, Buchbinder R, Lassere M, March L, Robinson P, Hill C, Barrett C, Carroll G, Marine F, Schachna L, Sinnathurai P. (2021) Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal. 51:788-792. doi:10.1111/imj.15309.
  • Robertson A, Birch M, Harris IA, Buchbinder R, Ferreira G, O’Keeffe M, Maher C, Zadro JR. (2021) Online information about the effectiveness of shoulder surgery is not evidence-based: A content analysis. Arch Phys Med Rehabil. S0003-9993(21)00376-2.
  • Rozbroj T, Haas R, O’Connor D, Carter SM, McCaffery K, Thomas R, Donovan J, Buchbinder R. (2021) How do people understand overtesting and overdiagnosis? Systematic review and meta-synthesis of qualitative research. Soc Sci Med 285:114255.
  • Rozbroj T, McCaffery K. (2021) The importance of addressing social inequalities and targeting the undecided to promote vaccination against COVID-19. The Lancet Regional Health – Western Pacific 14:100250.
  • Smith Z, Barnett SA, Gorelik A, Pascoe DM, Manser RL. (2021) Strategies for the management of solitary pulmonary nodules. A survey of patient preferences. Ann Thorac Surg. S0003-4975(21)00889-4. doi:10.1016/j.athoracsur.2021.04.094.
  • Thomas M, Fraenkel L, Boonen A, Bansback N, Buchbinder R, Marshall D,Proulx L, Voshaar M, Richards P, Richards D, Hiligsmann M, Guillemin F, Shea B, Tugwell P, Hazlewood G. (2021) Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group. Sem Arthritis Rheum. 51(4):919-924. doi:10.1016/j.semarthrit.2021.05.008.
  • Tonchev IR, Nam MCY, Gorelik A, Kumar S, Haqqani H, Sanders P, Kistler PM, Kalman JM. (2021) Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 23(7):1024-1032. doi:10.1093/europace/euaa415.
  • Venter G, Tieu J, Black R, Lester S, Leonardo N, Whittle SL, Hoon E, Barrett C, Rowett D, Buchbinder R, Hill CL. (2021) Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis. ACR Open Rheumatol. 3(4):231-238. doi:10.1002/acr2.11234.
  • Wallis J, Young K, Zayontz S, Risbey P, Buchbinder R. (2021) Utilisation of inpatient rehabilitation following elective total knee or hip replacements in private hospital setting declined during the COVID-19 pandemic. Int Med J. 51(3):446-447. doi:10.1111/imj.15095.
  • Wang L, Hong PJ, May C, Rehman Y, Oparin Y, Hong C, Hong BY, AminiLari M, Gallo L, Kaushal A, Craigie S, Couban RJ, Kum E, Shanthanna H, Price I, Upadhye S, Ware M, Campbell F, Buchbinder R, Agoritsas T, Busse JW. (2021) Medical cannabis for chronic pain: a systematic review and metaanalysis of randomized clinical trials. BMJ 373:n1034. doi: http://dx.doi.org/10.1136/bmj.n1034
  • Wertheimer G, Mathieson S, Maher CG, Lin CWW, McLachlan A, Buchbinder R, Pearson SA, Underwood M. (2021) The prevalence of ppioid analgesic use in people with chronic noncancer pain: Systematic review and meta-analysis of observational studies. Pain Medicine. 22(2):506-17. doi:10.1093/pm/pnaa322.
  • Whittle SL, Hazlewood GS, Robinson P, Johnston RV, Leder K, Glennon V, Avery JC, Grobler L, Buchbinder R. (2021) COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies (Protocol). Cochrane Database Sys Rev. 6: CD014991. doi:10.1111/1742-6723.13814.
  • Wiles L, Hibbert P, Stephens J, Molloy C, Maher CG, Buchbinder R, Moseley GL, O’Sullivan PB, Lin I, Briggs A, Slater H, Harris I, Jan S, Dwyer A, Fallon K, Hogg M, Fried K, Needs C, Casey P, Dabestani R, Kay D, Braithwaite J, Runciman W. (2021) What Constitutes “Appropriate Care” for Low Back Pain?: Point-of-Care Clinical Indicators From Guideline Evidence and Experts (the STANDING Collaboration Project). Spine. (Epub ahead of print) doi: 10.1097/BRS.0000000000004274.
  • Zadro JR, Jones C, Harris IA, Buchbinder R, O’Connor D, McCaffery K, Thompson R, Karunaratne S, Teng MJ, Maher C, Hoffmann T. (2021) Development of a patient decision aid on subacromial decompression surgery and rotator cuff repair surgery: an international mixed-methods study. BMJ Open 11(8):e054032. doi:10.1136/bmjopen-2021-05403
  • Zadro JR, O’Keeffe M, Ferreira GE, Haas R, Harris IA, Buchbinder R, Maher CG. (2021) Diagnostic labels for rotator cuff disease can increase people’s perceived need for shoulder surgery: An online randomised controlled experiment. J Orthop Sports Phys Ther. 51(8):401-411. doi:10.2519/jospt.2021.10375.
  • Zadro JR, Rischin A, Johnston R, Buchbinder R. (2021) Image-guided glucocorticoid injection versus injection without image guidance for shoulder pain (Updated review). Cochrane Database Sys Rev 8:CD009147